Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Casopitant mesylate | 414910-30-8 | 99.1% | C31H39F7N4O5S | 50 MG
SDP

Catalog No. 5000355784
Encompass_Preferred

Casopitant mesylate (GW679769B) is a potent, selective, brain-permeable, and orally active neurokinin 1 (NK1) receptor antagonist. It is classified as a second-in-class antiemetic that counteracts the emetogenic effect of Substance P. It is utilized for the treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

  • Potent, selective, brain-permeable, and orally active neurokinin 1 (NK1) receptor antagonist.
  • Antagonizes the emetogenic effect of Substance P.
  • Substrate and a weak-to-moderate inhibitor of CYP3A4.
  • Used for the treatment of chemotherapy-induced nausea and vomiting (CINV).
  • Used for the treatment of postoperative nausea and vomiting (PONV).

Catalog No. 50-003-55784 Supplier Medchemexpress LLC Supplier No. HY14405A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Casopitant mesylate (GW679769B) is a potent, selective, brain-permeable, and orally active neurokinin 1 (NK1) receptor antagonist. It is classified as a second-in-class antiemetic that counteracts the emetogenic effect of Substance P. It is utilized for the treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

  • Potent, selective, brain-permeable, and orally active neurokinin 1 (NK1) receptor antagonist.
  • Antagonizes the emetogenic effect of Substance P.
  • Substrate and a weak-to-moderate inhibitor of CYP3A4.
  • Used for the treatment of chemotherapy-induced nausea and vomiting (CINV).
  • Used for the treatment of postoperative nausea and vomiting (PONV).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.